Form 4 holding
Director
CRISPR Therapeutics AG
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 12,000
- Estimated value
- Report date
- 09 Jun 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount